Cytokinetics | CYTK - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Acadia Pharmaceuticals USD 0 0 2025-03
Amgen USD 51.86B 27M 2026-06
Bayer EUR 30.68B 1.15B 2026-03
Biogen USD 7.29B 1B 2026-06
Brainstorm Cell Therapeutics USD 0 0 2025-03
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Capricor Therapeutics USD 3.38M 0 2025-03
Cytokinetics USD 248.2M 993K 2026-06
Eisai JPY 184.6B 49.83B 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Geron USD 120.13M 298K 2026-06
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Ligand Pharmaceuticals USD 446.9M 704K 2026-03
Merck USD 51.08B 4.41B 2026-06
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.5B 70M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 14.65B 806M 2026-06